BDD Pharma Ltd offer service "BDD Swift - adaptive clinical studies"

BDD Swift is an adaptive clinical study approach that uses real-time in vivo clinical data to guide and optimize formulation design, letting sponsors make formulation-change decisions based on emerging results rather than waiting until late-stage testing. By integrating formulation development, GMP manufacturing, and clinical testing, it can shrink the time from initial prototype to clinical evaluation to as little as six months - addressing the trial-and-error nature of traditional sequential development, where in vitro tools offer no guarantee of in vivo success and problems often surface only after lengthy, costly development cycles; supplied from the United Kingdom.